Similar articles

• Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.

  Nam HS, Koh WJ, Kwon OJ, Cho SN, Shim TS. Nam HS, et al. Int J Antimicrob Agents. 2009 Jan;33(1):92-3. doi: 10.1016/j.ijantimicag.2008.06.014. Epub 2008 Sep 11. Int J Antimicrob Agents. 2009. PMID: 18789655 No abstract available.
• Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis.

  Yew WW, Chau CH, Wen KH. Yew WW, et al. Int J Tuberc Lung Dis. 2008 Mar;12(3):345-6. Int J Tuberc Lung Dis. 2008. PMID: 18284844 No abstract available.
• What is the optimal dosage of linezolid in treatment of complicated multidrug-resistant tuberculosis?

  Yew WW, Chang KC, Chau CH. Yew WW, et al. Eur Respir J. 2009 Dec;34(6):1492-4. doi: 10.1183/09031936.00111009. Eur Respir J. 2009. PMID: 19948917 No abstract available.
• Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid.

  Ang JY, Lua JL, Turner DR, Asmar BI. Ang JY, et al. Pediatr Infect Dis J. 2003 Dec;22(12):1101-3. doi: 10.1097/01.inf.0000101784.83146.0c. Pediatr Infect Dis J. 2003. PMID: 14688576 Review.
• [The analysis of clinical data about the treatment of linezolid against tuberculosis].

  Nie WJ, Chu NH. Nie WJ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2013 Aug;36(8):601-3. Zhonghua Jie He He Hu Xi Za Zhi. 2013. PMID: 24252739 Review. Chinese. No abstract available.